Determinants of self-monitoring of blood glucose with type 2 diabetes based on 496 questionnaire surveys in China

  • Xiaodong Guan
  • Lili Ma
  • Haishaerjiang Wushouer
  • Chunxia Man
  • Sheng Han
  • Luwen ShiEmail author
Original Article


The purpose of the study was to investigate the current status quo of self-monitoring of blood glucose (SMBG) levels and to analyze the relationship between demographics and other characteristics of SMBG among people with type 2 diabetes (T2D) in China. In this multicenter, cross-sectional study, 496 individuals with T2D from five provinces across China voluntarily participated in the study and completed a standardized questionnaire that requested information on demographic data, clinic-related information, and glucose monitoring. Data was obtained via face-to-face interviews. Negative binomial regression analysis was used to identify factors associated with SMBG. Of the total sample, 99 (20.0%) participants had never performed SMBG and/or less than once. We found that 104 participants (21.0%) had tested just once. In addition 119 people (24.0%) had tested twice, 89 (18.0%) had tested between three and six times, and 85 participants (17.1%) had tested more than seven times in a week. Univariate analysis and multivariate analysis found that the patients that had high monitoring frequencies were those with URBMI, UEBMI, and GMI insurance; those who had previously experienced complications; inpatients; and those with a knowledge of HbA1c testing. The frequency of SMBG was suboptimal, compared with the once prior to each meal recommendation by the American Diabetes Association (ADA). Several factors influenced SMBG frequency: types of health insurance, complications, impatience, and knowledge of HbA1c.


Type 2 diabetes Self-monitoring of blood glucose Continuous glucose monitoring 



We thank all the investigation centers for their cooperation and all the endocrinologists for their assisting in collecting the data.

Compliance with ethical standards

Conflict of interests

The authors declare that they have no conflict of interest.

Ethical standard

Our study was a retrospective survey, using data from patients over the past period of time, so we simply obtained verbal consent from all patients during the interview.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    World Health Organization(WHO). The top 10 causes of death. Accessed April 6, 2017.
  2. 2.
    LiaoMM, YinTT, ShiSH, KongY.The current status of compliance and coping styles of diabetes patients. Nurs J Chin People's Liberation Army2012;11:30–32.[in Chinese].Google Scholar
  3. 3. International Diabetes Federation. Diabetes Atlas. 7th edition. Accessed April 6, 2017.
  4. 4.
    Rahelić D. 7th edition of IDF diabetes atlas—call for immediate action. Lijec Vjesn. 2016;138(1–2):57–8.Google Scholar
  5. 5.
    Le C, Lin L, Jun D, Jianhui H, Keying Z, Wenlong C. The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiology. 2013;165(2):273–7. Scholar
  6. 6. Global guideline for type 2 diabetes. Accessed April 6, 2017.
  7. 7.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2013;36:S11–S66.Google Scholar
  8. 8.
    JiaW P. Chinese clinical guideline for continuous glucose monitoring (2012) Chin Med J, 2012, 125(23):4167.Google Scholar
  9. 9.
    Franciosi M, Pellegrini F, De BG, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care. 2001;24(11):1870–7.CrossRefGoogle Scholar
  10. 10.
    Ruiz GT, García d l TLN, Durán RHA, Calle Pascual AL. Structured SMBG in early management of T2DM: contributions from the St Carlos study. World J Diabetes. 2014;5(4):471–81. Scholar
  11. 11.
    Bolzetta F. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Suppl 1):S11–61.Google Scholar
  12. 12.
    Emanuele B, Marina S, Antonio C, et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes. Diabetes Care. 2013;36(10):2887–94. Scholar
  13. 13.
    Brunisholz KD, Briot P, Hamilton S, et al. Diabetes self-management education improves quality of care and clinical outcomes determined by a diabetes bundle measure. J Multidisciplinary Healthcare. 2014;2014(default):533–42.CrossRefGoogle Scholar
  14. 14.
    Gomes MB, Tannus LR, Cobas RA, et al. Determinants of self-monitoring of blood glucose in patients with type 1 diabetes: a multi-centre study in Brazil. Diabet Med. 2013;30(10):1255–62.CrossRefGoogle Scholar
  15. 15.
    Yuan L, Guo X, Xiong Z, Lou Q, Shen L, Zhao F, et al. Self-monitoring of blood glucose in type 2 diabetic patients in China: current status and influential factors. Chin Med J. 2014;127(2):201–7.Google Scholar
  16. 16.
    Toljamo M, Hentinen M. Adherence to self-care and glycaemic control among people with insulin-dependent diabetes mellitus. J Adv Nursing. 2001;34(6):780–6.CrossRefGoogle Scholar
  17. 17.
    Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112–25. Scholar
  18. 18.
    Hill JO, Galloway JM, Goley A, Marrero DG, Minners R, Montgomery B, et al. Scientific statement: socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care. 2013;36(8):2430–9. Scholar
  19. 19.
    Espelt A, Arriola L, Borrell C, Larrañaga I, Sandín M, Escolar-Pujolar A. Socioeconomic position and type 2 diabetes mellitus in europe 1999. Curr Diabetes Rev. 1999;7(3):148–58.CrossRefGoogle Scholar
  20. 20.
    Negandhi PH, Ghouri N, Colhoun HM, Fischbacher CM, Lindsay RS, McKnight JA, et al. Ethnic differences in glycaemic control in people with type 2 diabetes mellitus living in Scotland. PLoS One. 2013;8(12):e83292. Scholar
  21. 21.
    Wambui CK, Kumar AM, Hinderaker SG, et al. Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya. Diabetes Res Clin Pract. 2016;112:37–43.CrossRefGoogle Scholar
  22. 22.
    Cano-BlanquerD, Cervera-CasinoP, Peiró-MorenoS, Mateu-GarcíaM., Barreda-AznarA., Grupo de Estudio de la Automonitorización Glucémica Prevalence and associated factors in self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients in the Valencia Community, Spain [J]. Rev Esp Salud Publica, 2013, 87(2):149–163. doi:
  23. 23.
    WHO.Consultation. Consultation, definition, diagnosis and classification of diabetes mellitus and its complications. Part l: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999. p. 1–59.Google Scholar
  24. 24.
    Delgado-Pérez VJ, De La Rosa-Santillana R, Márquez-Corona ML, Ávila-Burgos L, Islas-Granillo H, Minaya-Sánchez M, et al. Diabetes or hypertension as risk indicators for missing teeth experience: an exploratory study in a sample of Mexican adults. Niger J Clin Pract. 2017;20:1335–41.CrossRefGoogle Scholar
  25. 25.
    Pan CY, The Investigated Cooperation Group of China. The status of diabetes control in China: the gap between guideline and practice. Section Endocrinol Foreign Med Sci. 2005;3:174–8. [in Chinese]Google Scholar
  26. 26.
    Wilson V. Economic change: a barrier to diabetes self-management? Primary Health Care. 2011;21:27–30.CrossRefGoogle Scholar
  27. 27.
    Helgeson VS, Honcharuk E, Becker D, Escobar O, Siminerio L. A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency. Pediatr Diabetes. 2011;12(1):25–30. Scholar
  28. 28.
    Adams AS, Mah C, Soumerai SB, et al. Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study. BMC Health Serv Res. 2003;3(1):1–8.CrossRefGoogle Scholar
  29. 29.
    Xu Y, Toobert D, Savage C, Pan W, Whitmer K. Factors influencing diabetes self-management in Chinese people with type 2 diabetes. Res Nurs Health. 2008;31(6):613–25. Scholar

Copyright information

© Research Society for Study of Diabetes in India 2018

Authors and Affiliations

  1. 1.School of Pharmaceutical SciencesPeking UniversityBeijingChina
  2. 2.International Research Center for Medicinal AdministrationPeking UniversityBeijingChina

Personalised recommendations